Company Overview
Snapshot
Founded in January 2012 by Gil Shalev, Equinom operates with 11–50 employees. The company has raised a total of $75.25 million across 5 funding rounds from 13 investors. In December 2022, Equinom secured a D Round of funding led by Synthesis Capital, signaling continued investor confidence in its innovative approach to plant-based ingredients.
Business overview
Equinom specializes in developing non-GMO seed varieties to create nutritious food ingredients. The company leverages AI and computational breeding with its proprietary seed bank to enhance natural crop diversity. This approach allows Equinom to custom-design ingredients with superior protein content, organoleptic qualities, and nutritional value, while also minimizing processing requirements. Serving the food and ingredient industries, Equinom operates within the Agriculture & Food Technologies sector, focusing on sustainable farming, sustainable proteins, and novel food ingredients.
Strategic signal
In August 2024, Equinom's AI-driven Manna Technology became commercially available for high-protein pea production. This development signifies a major step in scaling the company's proprietary breeding technology, enabling broader access to optimized plant-based ingredients for the food industry. For investors, this indicates a strong commercialization trajectory and potential for significant market penetration in the rapidly expanding alternative protein sector.
Log in to access full profile ›Company Intelligence Q&A
- What was Equinom's most recent funding round?
- In December 2022, Equinom secured a D Round of funding. The round was led by Synthesis Capital and included participation from Bunge Ventures.
- When did Equinom raise its C Round?
- In June 2021, Equinom raised a C Round of funding. Phoenix Insurance led the round, with follow-on investment from Fortissimo Capital.
- Which investors participated in Equinom's B Round?
- In February 2020, Equinom's B Round was led by BASF Venture Capital, with follow-on investment from.
- What was a significant product development for Equinom?
- In August 2024, Equinom's AI-driven Manna Technology became commercially available for high-protein pea production, marking a key advancement in its ingredient offerings.
- Did Equinom expand its market presence in the US?
- In March 2020, Equinom entered the US market with its non-GMO seed breeding technology, aiming to transform the plant-based food industry in the region.